Personalized Treatment in Epilepsyhighlights the individualized- and subgroup-based approaches in diagnosing, treating, and monitoring epilepsy. Whereas the term ‘‘personalized medicine’’ is used to describe the focus on individual patients, ‘‘stratified medicine’’ refers to the definition of population subgroups based on estimates of their differences in the etiology and prognosis of epilepsy, or response to treatment. The book describes the various aspects of personalized and stratified approaches in epilepsy, the potential of these approaches to improve the cost-effectiveness of epilepsy treatment, and barriers to their implementation. The book assists clinicians in rationally choosing the required diagnostic and treatment means for their patients, out of the abundance of available technologies and products. By doing so, they will provide better care, mitigating adverse events, expediting the reach of effective treatment, and reducing costs. The target audience is anyone involved in developing and delivering diagnostic means and treatment for people with epilepsy, including epileptologists, other neurologists, neurosurgeons, pharmacists, nurses, technicians, geneticists, researchers
- Comprehensively describes individualized and stratified treatment approaches in epilepsy
- Assists clinicians with rationally choosing the required diagnostic and treatment means for their patients
- Diagnosis, drugs, non-pharmacological treatments, and future research are all discussed in depth
